⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer

Official Title: JCOG1801: A Phase III Randomized Controlled Trial Comparing Surgery Plus Adjuvant Chemotherapy With Preoperative Chemoradiotherapy Followed by Surgery Plus Adjuvant Chemotherapy for Locally Recurrent Rectal Cancer (RC-SURVIVE Study)

Study ID: NCT04288999

Study Description

Brief Summary: JCOG1801 is a randomized phase III trial which was initiated in Japan in August 2019 to confirm the superiority of preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy for local relapse-free survival over standard treatment, i.e. surgery plus adjuvant chemotherapy, for previously non-irradiated locally recurrent rectal cancer.

Detailed Description: In all, 110 patients from 43 Japanese institutions will be recruited over a period of 6 years. Eligible patients would be registered and randomly assigned to each group with an allocation ratio of 1:1. The primary endpoint is local relapse-free survival. The secondary endpoints are overall survival, relapse-free survival, proportion of local relapse, proportion of distant relapse, proportion of patients with pathological R0 resection, response rate of preoperative chemoradiotherapy (preoperative chemoradiotherapy arm), pathological complete response rate (preoperative chemoradiotherapy arm), proportion of patients who completed the protocol treatment, incidence of adverse events (adverse reactions), and quality of life after surgery.

Eligibility

Minimum Age: 20 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Chiba Cancer Center, Chiba, , Japan

Gifu University School of Medicine, Gifu, , Japan

Saitama Medical University International Medical Center, Hidaka, , Japan

Kansai Medical University Hospital, Hirakata, , Japan

Hiroshima City Asa Citizens Hospital, Hiroshima, , Japan

Hiroshima City Hospital, Hiroshima, , Japan

Shimane University Faculty of Medicine, Izumo, , Japan

Ishikawa Prefectural Central Hospital, Kanazawa, , Japan

National Cancer Center Hospital East, Kashiwa, , Japan

Saitama Medical Center, Saitama Medical University, Kawagoe, , Japan

Kochi Health Sciences Center, Kochi, , Japan

Kumamoto University Hospital, Kumamoto, , Japan

Kurashiki Central Hospital, Kurashiki, , Japan

Kurume University School of Medicine, Kurume, , Japan

National Hospital Organization Shikoku Cancer Center, Matsuyama, , Japan

Kyorin University Faculty of Medicine, Mitaka, , Japan

Iwate Medical University, Morioka, , Japan

Nagoya University Graduate School of Medicine, Nagoya, , Japan

Niigata Cancer Center Hospital, Niigata, , Japan

Hyogo College of Medicine, Nishinomiya, , Japan

Okayama Saiseikai General Hospital, Okayama, , Japan

National Hospital Organization Osaka National Hospital, Osaka, , Japan

Osaka City General Hospital, Osaka, , Japan

Saitama Cancer Center, Saitama, , Japan

Sapporo-Kosei General Hospital, Sapporo, , Japan

Miyagi Cancer Center, Sendai, , Japan

Shizuoka Cancer Center, Shizuoka, , Japan

Osaka University Graduate School of Medicine, Suita, , Japan

Suita Municipal Hospital, Suita, , Japan

Osaka Medical College, Takatsuki, , Japan

National Defense Medical College, Tokorozawa, , Japan

National Cancer Center Hospital, Tokyo, , Japan

Toho University Ohashi Medical Center, Tokyo, , Japan

Toho University Omori Medical Center, Tokyo, , Japan

Tokyo Medical and Dental University Hospital, Tokyo, , Japan

Tokyo Medical University Hospital, Tokyo, , Japan

Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, , Japan

Tochigi Cancer Center, Utsunomiya, , Japan

Yamagata Prefectural Central Hospital, Yamagata, , Japan

Kanagawa Cancer Center, Yokohama, , Japan

Saiseikai Yokohama-shi Nanbu Hospital, Yokohama, , Japan

Yokohama City University Medical Center, Yokohama, , Japan

Oita University Faculty of Medicine, Yufu, , Japan

Ogaki Municipal Hospital, Ōgaki, , Japan

Gunma Prefectural Cancer Center, Ōta, , Japan

Contact Details

Name: Masaaki Ito, MD, PhD

Affiliation: National Cancer Center Hospital East

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: